Back

Cardiotrophin-1 and components of metabolic syndrome: what is the role in the development of atrial fibrillation?

24 April 2021 (07:30 - 08:30)
Organised by:
Congress Presentation Part of: Pathophysiology of atrial fibrillation and beyond II Pathophysiology and Mechanisms, Other EHRA Premium Access EHRA 2021

About the speaker

Photo
Assistant Professor Valery Ionin

Saint Petersburg First Pavlov State Medical University, Saint Petersburg (Russian Federation)

6 More presentations in this session

Presentation thumbnail
Conduction and voltage characteristics associated with new-onset postoperative atrial fibrillation
Mr M. Van Schie (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Acute atrial ischemia associates with early but not late new-onset atrial fibrillation in STEMI patients treated with primary PCI: relationship with in-hospital outcomes.
Doctor F. Biccire (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Application of recurrence plot analysis to characterise whole chamber propagation of atrial fibrillation
Doctor M. Pope (Southampton, GB)
Abstract Slides Video
Presentation thumbnail
The onset of paroxysmal non-valvular atrial fibrillation in men with hypertension is associated with an increase in blood levels of transforming growth factor beta 1
Professor S. Koval (Kharkiv, UA)
Abstract Slides Video
Presentation thumbnail
Outcomes of heart failure with preserved ejection fraction after radiofrequency catheter ablation for atrial fibrillation
Assistant Professor T. Zolotarova (Montreal, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology of atrial fibrillation and beyond II

The Event

Event poster

EHRA 2021

24 April 2021 07:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources